137 related articles for article (PubMed ID: 29953974)
1. Etoricoxib and Diclofenac Might Reduce the Risk of Dementia in Patients with Osteoarthritis: A Nation-Wide, Population-Based Retrospective Cohort Study.
Xue YH; Peng YS; Ting HF; Peijer Hsieh J; Huang YK; Wang YH; Chiou JY; Wei JC
Dement Geriatr Cogn Disord; 2018; 45(5-6):262-271. PubMed ID: 29953974
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Cannon CP; Curtis SP; Bolognese JA; Laine L;
Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
[TBL] [Abstract][Full Text] [Related]
3. Osteoarthritis increases the risk of dementia: a nationwide cohort study in Taiwan.
Huang SW; Wang WT; Chou LC; Liao CD; Liou TH; Lin HW
Sci Rep; 2015 May; 5():10145. PubMed ID: 25984812
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
Baraf HS; Fuentealba C; Greenwald M; Brzezicki J; O'Brien K; Soffer B; Polis A; Bird S; Kaur A; Curtis SP;
J Rheumatol; 2007 Feb; 34(2):408-20. PubMed ID: 17304660
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.
Feng X; Tian M; Zhang W; Mei H
PLoS One; 2018; 13(1):e0190798. PubMed ID: 29320568
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Zacher J; Feldman D; Gerli R; Scott D; Hou SM; Uebelhart D; Rodger IW; Ozturk ZE;
Curr Med Res Opin; 2003; 19(8):725-36. PubMed ID: 14687444
[TBL] [Abstract][Full Text] [Related]
8. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis.
van Walsem A; Pandhi S; Nixon RM; Guyot P; Karabis A; Moore RA
Arthritis Res Ther; 2015 Mar; 17(1):66. PubMed ID: 25879879
[TBL] [Abstract][Full Text] [Related]
9. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
Krum H; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP
Eur J Heart Fail; 2009 Jun; 11(6):542-50. PubMed ID: 19380329
[TBL] [Abstract][Full Text] [Related]
10. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.
Laine L; Curtis SP; Langman M; Jensen DM; Cryer B; Kaur A; Cannon CP
Gastroenterology; 2008 Nov; 135(5):1517-25. PubMed ID: 18823986
[TBL] [Abstract][Full Text] [Related]
11. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of stroke in patients with osteoarthritis: a population-based cohort study.
Hsu PS; Lin HH; Li CR; Chung WS
Osteoarthritis Cartilage; 2017 Jul; 25(7):1026-1031. PubMed ID: 28300652
[TBL] [Abstract][Full Text] [Related]
14. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
[TBL] [Abstract][Full Text] [Related]
15. Association of tramadol with risk of myocardial infarction among patients with osteoarthritis.
Wei J; Wood MJ; Dubreuil M; Tomasson G; LaRochelle MR; Zeng C; Lu N; Lin J; Choi HK; Lei G; Zhang Y
Osteoarthritis Cartilage; 2020 Feb; 28(2):137-145. PubMed ID: 31629022
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S
Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490
[TBL] [Abstract][Full Text] [Related]
17. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
Emery P; Koncz T; Pan S; Lowry S
Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
[TBL] [Abstract][Full Text] [Related]
18. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
Curtis SP; Bockow B; Fisher C; Olaleye J; Compton A; Ko AT; Reicin AS
BMC Musculoskelet Disord; 2005 Dec; 6():58. PubMed ID: 16321158
[TBL] [Abstract][Full Text] [Related]
19. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
[TBL] [Abstract][Full Text] [Related]
20. Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study.
Li L; Marozoff S; Lu N; Xie H; Kopec JA; Cibere J; Esdaile JM; Aviña-Zubieta JA
Arthritis Res Ther; 2022 Apr; 24(1):85. PubMed ID: 35410440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
